Medical comorbidity associated with psoriasis in adults: A population-based study

British Journal of Dermatology

Volumn 165, Issue 5, 2011, Pages 1037-1043

  Yang, Y W ^b   Keller, J J ^a   Lin, H C ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASTHMA; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; TAIWAN; AGED; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; MIDDLE AGED; SOCIOECONOMICS;

ADULT; AGED; CASE-CONTROL STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PSORIASIS; SOCIOECONOMIC FACTORS; TAIWAN;

EID: 84856380714     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10494.x     Document Type: Article

References (33)

1. Schon MP, Boehncke WH. Psoriasis. N Engl J Med 2005; 352:1899-912. (Pubitemid 40627816)
2. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296:1735-41. (Pubitemid 44547793)
3. Cohen AD, Weitzman D, Dreiher J. Psoriasis and hypertension: a case-control study. Acta Derm Venereol (Stockh) 2010; 90:23-6.
4. Christophers E. Comorbidities in psoriasis. Clin Dermatol 2007; 25:529-34. (Pubitemid 350087599)
5. Sommer DM, Jenisch S, Suchan M et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298:321-8.
6. Rapp SR, Feldman SR, Exum ML et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41:401-7. (Pubitemid 29418506)
7. Sampogna F, Tabolli S, Soderfeldt B et al. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006; 154:844-9.
8. Burden AD. Health economics and the modern management of psoriasis. Br J Dermatol 2010; 163:670-1.
9. Kimball AB, Guerin A, Tsaneva M et al. Economic burden of com-orbidities in patients with psoriasis is substantial. J Eur Acad Dermatol Venereol 2011; 25:157-63.
10. Prodanovich S, Kirsner RS, Kravetz JD et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009; 145:700-3.
11. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-26. (Pubitemid 29054847)
12. Vena GA, Vestita M, Cassano N. Psoriasis and cardiovascular disease. Dermatol Ther 2010; 23:144-51.
13. Feldmann E, Daneault N, Kwan E et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40:1541-5. (Pubitemid 20351346)
14. Leung SY, Ng TH, Yuen ST et al. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke 1993; 24:779-86. (Pubitemid 23163548)
15. Bang OY, Lee PH, Yoon SR et al. Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry 2005; 76:1128-34. (Pubitemid 41081289)
16. Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial. Neuroepidemiology 2003; 22:37-40. (Pubitemid 36131972)
17. Liu ZZ, Lv H, Gao F et al. Polymorphism in the human C-reactive protein (CRP) gene, serum concentrations of CRP, and the difference between intracranial and extracranial atherosclerosis. Clin Chim Acta 2008; 389:40-4.
18. Shapiro J, Cohen AD, David M et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007; 56:629-34. (Pubitemid 46400186)
19. Augustin M, Reich K, Glaeske G et al. Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol (Stockh) 2010; 90: 147-51.
20. Brenelli SL, Moraes AM, Monte-Alegre S et al. Insulin resistance in psoriasis. Braz J Med Biol Res 1995; 28:297-301.
21. Ucak S, Ekmekci TR, Basat O et al. Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis. J Eur Acad Dermatol Venereol 2006; 20:517-22.
22. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116:1793-801. (Pubitemid 44033299)
23. Spranger J, Kroke A, Mohlig M et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC) - Potsdam Study. Diabetes 2003; 52:812-17. (Pubitemid 36323590)
24. Liu S, Tinker L, Song Y et al. A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of post-menopausal women. Arch Intern Med 2007; 167:1676-85. (Pubitemid 47280350)
25. Szepietowski JC, Bielicka E, Wasik F et al. Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol 2000; 14:513-14. (Pubitemid 32899279)
26. Cecchi R, Seghieri G, Gironi A et al. Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology 1992; 185:93-5.
27. Taglione E, Vatteroni ML, Martini P et al. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatol 1999; 26:370-2. (Pubitemid 29066741)
28. Palazzi C, Olivieri I, D'Amico E et al. Hepatitis C virus infection in psoriatic arthritis. Arthritis Rheum 2005; 53:223-5. (Pubitemid 40530162)
29. Cohen AD, Weitzman D, Birkenfeld S et al. Psoriasis associated with hepatitis C but not with hepatitis B. Dermatology 2010; 220:218-22.
30. Ahmad QM, Sameem F, Shah IH. Prevalence of hepatotrophic viruses B & C in psoriasis. Indian J Dermatol Venereol Leprol 2005; 50:200-2.
31. Gisondi P, Del Giglio M, Cozzi A et al. Psoriasis, the liver, and the gastrointestinal tract. Dermatol Ther 2010; 23:155-9.
32. Gisondi P, Targher G, Zoppini G et al. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009; 51:758-64.
33. Miele L, Vallone S, Cefalo C et al. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol 2009; 51:778-86.